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INTRODUCTION
Mastitis is the most widespread disease in dairy cattle affecting animal health and
the disease results in serious financial losses to dairy farmers (Pol and Ruegg, 2007).
Currently, intramammary (IMM) infusion of antibiotics to treat mastitis is the single
greatest reason for the use of antibiotics in dairy cows (Pol and Ruegg, 2007).
In the United States, there are a limited number of antibiotics approved for IMM
treatment of mastitis (Pol and Ruegg, 2007). β-lactams are the primary class of
antibiotics that have been approved by the Food and Drug Administration (FDA) for the
treatment of mastitis (Holstege et al., 2002). To ensure human food safety, the FDA is
responsible for establishing milk withholding times, “safe” or “tolerance” levels for
antibiotics in milk, and analyzing all bulk types of commingled milk for the presence of
β-lactam and other drug residues. To detect violative concentrations of these residues in
milk, the FDA uses qualitative, rapid antibiotic residue screening tests to monitor for
β-lactams and other classes of antibiotics and drugs (FDAa, 1997).
Detecting violative levels of antimicrobial residues in commingled milk through
the use of residue screening tests can help prevent contaminated milk from entering the
human food supply. Testing at this level, however, does not protect the dairy producer
from the loss of milk and financial penalties due to a contaminated bulk tank (Andrew,
2000). Although milk is not regulated at the individual cow basis, a study conducted by
McEwen et al. (1991) determined that the use of antibiotic screening tests for milk from
individual cows was associated with reduced risk of bulk milk residue incidence when
used under field conditions.
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Even though commingled milk is tested for antibiotic residues, some consumers
remain concerned about the possibility for contaminants in milk (Hillerton et al., 1999).
Concerns regarding the perceived or potential harmful effects of antibiotic residues in
milk have, in part, driven the consumer demand for organically produced dairy products
(McEwen et al., 1991), where the use of antibiotics in cows supplying milk for organic
production is prohibited (Pol and Ruegg, 2007). Dairy products are only second (16%) to
fruits and vegetables (40%) in organic food purchases (Organic Trade Association,
2007). The demand for organic milk is predicted to grow and potentially may result in a
dramatic increase in the proportion of dairy farms transitioning to organic practices
(Ruegg, 2009).
In the United States, organic milk can only come from cows that have never been
treated with an antibiotic (Karreman, 2007) and there are no “natural products” that have
been evaluated and approved by the FDA for IMM use. There are many natural remedies
that are topical and pose little risk for contamination of milk or meat (Ruegg, 2009). A
few of these “natural treatments” have the potential to be efficacious in treating mastitis
by IMM infusion; however, research is lacking to support the efficacy of these
compounds.
Natural antimicrobials such as caprylic acid, eugenol, trans-cinnamaldehyde,
carvacrol, and thymol have been found to be inhibitory, in vitro, towards an array of
pathogenic microorganisms and may be potential candidates for efficacious nonantibiotic treatments for mastitis (Ananda Baskaran et al., 2008, Nair et al., 2005). If so,
then evaluation of possible residues would be an important part of the use of these
compounds in commercial practice.
2

Screening tests may prove to be a valuable tool in evaluating the presence of
“natural” antimicrobials in milk, even if there are no human health concerns with the
residues of these compounds. Other concerns of “natural compounds” in milk may be the
effect on the taste of milk or interfering with the culturing process for cheese and yogurt.
Antibiotic residue screening tests may be useful to regulatory agencies, processing plants
and producers for assurance of safety of milk produced by conventional and organic dairy
farms, if the test can detect “natural antimicrobials.” This study evaluated the efficacy of
antibiotic residue screening tests for the detection of natural antimicrobials in milk.

LITERATURE REVIEW
Mastitis
Mastitis is considered the most prevalent and expensive disease of dairy cattle
worldwide. Specifically, mastitis is an inflammatory reaction of the mammary gland
usually in response to pathogenic microorganisms. An infection occurs when
microorganisms breach the teat canal and multiply within the mammary gland thus
eliciting the inflammatory response. Infections may be clinical or subclinical, depending
on the extent of inflammation (Schrick et al., 2001).
Clinical mastitis is distinguished by visible abnormalities in the appearance of the
udder or milk. The infected quarter may be swollen, tender, and warm. Decreased milk
production and alterations in the milk such as the presence of clots, flakes, and
discoloration may also be apparent in clinical cases (Philpot and Nickerson, 1991).
Subclinical mastitis is more subtle and is not detected by visual observation and
can only be identified from a culture of milk containing the mastitis causing pathogen. A
3

possible sign of subclinical mastitis is that the cow may have an increased somatic cell
count (SCC) due to the infection. The subclinical form is significantly more common
than the clinical form (Philpot and Nickerson, 1991). Subclinical mastitis can also cause
a chronic decrease in milk production that results in several thousand pounds of milk lost
per year (yr), if left untreated (Philpot and Nickerson, 1991).
Depending on the causative agent, mastitis can be broadly classified into
contagious mastitis and environmental mastitis. Contagious microorganisms reside in the
mammary gland and can spread from one cow to another during the milking process.
Environmental microorganisms, however, are found in the surroundings in which a cow
is housed and can infect the mammary gland usually at times other than milking.
Staphylococcus aureus, Streptococcus agalactiae, and Mycoplasma bovis are the primary
pathogens that cause contagious mastitis. The primary pathogens that cause
environmental mastitis are Klebsiella pneumoniae, Escherichia coli, Streptococcus
dysgalactiae, and Streptococcus uberis. Although, contagious pathogens are responsible
for the majority of mastitis cases, environmental pathogens are becoming a principal
concern as well (Pyörälä, 2002; Erskine et al., 2003).
Mastitis is the single most expensive disease in the dairy industry. Mastitis can
lead to severe economic losses due to reduced milk production, discarded milk, culling,
delayed genetic progress, veterinary services, and medication (Philpot and Nickerson,
1991). Worldwide losses are estimated to be $35 billion (Wellenberg et al., 2002). The
National Mastitis Council of the United States estimated the annual dollar loss to the
dairy industry due to mastitis to be approximately $2 billion. In another perspective, this
amounts to approximately $180 per cow per yr (Harmon, 1996). Since mastitis is both an
4

animal health concern and economic concern, it is in the producer’s best interest to act
swiftly to prevent and combat the disease.
Treatments for Mastitis
The most common method available for treating mastitis is IMM infusion of
antibiotics. In the United States., there are a limited number of antimicrobial drugs that
can be marketed for IMM treatment of mastitis. The current FDA approved antibiotic
classes include β-lactams, macrolides (erythromycin), coumarines (novobiocin), and
lincosamides (pirlimycin) (Pol and Ruegg, 2007). Of these four classes, β-lactams are the
most common antibiotics used for IMM treatment of mastitis on conventional dairy farms
(Pol and Ruegg, 2007). The six main antimicrobials that make up the β-lactam class are
ampicillin, amoxicillin, ceftiofur, cephapirin, cloxacillin, and penicillin G (Holstege et
al., 2002).
The use of IMM antibiotics at dry off is common in United States dairy facilities.
Dry cow therapy (DCT) is usually administered as a treatment for existing subclinical
cases of mastitis and as a means of prevention during the non-lactating period (Pol and
Ruegg, 2007). There are a number of advantages for DCT including; the cure rate is
generally greater than when treated during lactation, higher concentrations of long-lasting
antibiotics may be used safely, the incidence of new infections during the dry period is
reduced, and salable milk is not contaminated with drug residues (Philpot and Nickerson,
1991). A national survey of dairy herds (USDA/APHIS/VS/CEAH, 2005) reported that
more than 75% of producers administered IMM DCT in all cows within a herd. The
sample survey reported that cephapirin was the most commonly used IMM antibiotic
(42%), followed by penicillin (32%), and cloxacillin (13%) (Pol and Ruegg, 2007).
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Even though the most common mastitis treatment is IMM infusion of antibiotics,
this method has some limitations. The cure rates are generally low against many mastitis
causing agents. The cure rates of Staphylococcus aureus infections, for example,
typically vary between 20 and 78% (Dingwell et al, 2003). Another concern is the
overuse of antibiotics to treat bacterial diseases in cattle which has been suggested as a
catalyst for the emergence of antibiotic-resistant strains of bacteria (White, 1999).
Additionally, antibiotics used to treat mastitis have been implicated to be the most
common source of harmful drug residues in milk (Erskine, 1996). Approximately 90%
of inhibitory residues detected in milk over a five yr span in Michigan originated from
antibiotic treatment for mastitis (Erskine et al., 2003). Due to these concerns,
commingled milk must be monitored closely to avoid violative levels of antibiotic
residues.
FDA regulations for the presence of antibiotics in milk
The presence of antibiotic residues in milk is a primary concern for the dairy
industry. These residues have been linked to allergic reactions (in sensitive individuals),
emergence of resistant bacterial strains, and the impairment of bacterial fermentation
processes (Sierra et al., 2009).
The FDA is responsible for regulating commingled milk. In 1991, the FDA, with
the support of the National Conference on Interstate Milk Shipments (NCIMS), initiated
the National Drug Residue Milk Monitoring Program (NDRMMP) (FDAa, 1997).
The NDRMMP is designed to provide an estimate of the rate of animal drug
residues that may be present in milk. Under the NDRMMP, all tankers of milk in the
United States must be screened for residues of β-lactam antibiotic drugs. The only way
6

to comply with this requirement, without delaying the delivery of milk, is through the use
of rapid, qualitative antibiotic residue screening tests (Kijak, 2004).
The FDA developed a validation program for these screening tests for regulatory
use. To be considered for regulatory uses, a screening test must be able to detect four of
the six β-lactam antibiotic drugs, at or below the legal tolerance level or “safe level”
(Kijak, 2004). Milk containing antibiotic residues at or above FDA established tolerance
or “safe levels” are considered violative. Residues in concentrations below the
established levels are not considered to be of public health or regulatory significance
(FDAa, 1997). The program has been successful as evidenced by a marked decrease in
violative levels of milk from 0.104% in 1996 to 0.026% in 2009 (FDAb, 1997, FDAb,
2010).
There are strict financial penalties for producers if antibiotic residues are detected
at or above the tolerance or “safe” levels in their milk. The producer’s Grade “A” permit
will be suspended and not reinstated until their farm is investigated and the cause of the
contamination is identified and corrected. The producer must also discard all their milk
for a withholding period, ranging from one to three days. In addition, the producer must
purchase any other farms’ milk that was mixed on the tanker truck. The producer is also
responsible for the cost of transportation and disposal fees (FDAa, 1997).
Antibiotic Residue Screening Tests
Antibiotic residues must be monitored to prevent contaminated milk from
entering the human food supply. The best way to monitor commingled milk is through
the use of residue screening tests. These tests are rapid, qualitative, and can detect a
broad range of antibiotic residues (Navrátilová, 2008).
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Dairy facilities and government agencies use residue screening tests to comply
with the NCIMS requirement that all tankers of milk in the United States must be
screened for β-lactam antibiotic residues (Kijak, 2004).
There are many different types of FDA approved antibiotic residue screening
tests that may be used to detect the presence of β-lactam drug residues. The most
commonly used screening tests include microbial growth inhibition assays, microbial
receptor assays, receptor binding assays, immunologic assays, and enzymatic assays
(Kang et al., 2005).
Microbial growth inhibition assays make use of a standard culture of the tested
microorganism (i.e. Bacillus stearothermophilus) in a solid or liquid medium. The milk
sample is added to the agar surface and allowed to incubate. Over the duration of
incubation, the sample diffuses into the medium, if the sample contains inhibitor agents
such as β-lactam drug residues, reduction or complete inhibition occurs of the tested
microorganism growth (Navrátilová, 2008). Microbial growth inhibition assays differ in
the type of the testing organism, indicator, incubation period and temperature, and
detection levels of the agents analyzed. One of the most common microbial inhibition
tests is the Delvotest® which is used primarily as an “on-farm” screening method for bulk
tank and individual cow’s milk (Andrew, 1997).
The Delvotest® is qualitative, sensitive, and detects a broad range of antibiotics
based on the rapid growth and acid production of the test organism, Bacillus
stearothermophilus var. calidolactis (Kang et al., 2005). The test kit consists of agar
ampoules containing spores of the test organism and nutrient. The spores of the
bacterium will germinate and produce carbonic acid after the addition of milk and
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subsequent incubation. The production of carbonic acid causes the bromocresol purple
indicator in the ampoule to change color from purple to yellow. An ampoule that has
turned yellow after incubation is indicative of a negative sample. When antimicrobials
are present in the milk sample, the growth of the bacteria is inhibited and the color of the
agar remains purple, signifying a positive result (LeBreton et al., 2006). The advantages
of this type of assay include a wide detection spectrum, ease of use, and ability to screen
for a large number of samples (Navrátilová, 2008).
Receptor binding assays are also a common class of antibiotic residue screening
tests. This type of assay involves a receptor protein conjugated to an enzyme. The
conjugate will bind to free β-lactam antibiotics that may be present in the milk sample
(Navratilova, 2008). One of the most common receptor binding assays is the IDEXX
β-Lactam SNAP test.
The β-lactam SNAP test is an enzyme-linked, receptor binding assay in which
β-lactams are captured by a binding protein on a solid support adsorbent matrix. The
enzyme conjugate binds with the β-lactams present in the milk and the mixture is then
transferred to the sample well of the device. The sample travels on a filter paper strip
until it passes to the test spot. The test spot is coated with β-lactam antibiotic which
causes free receptors to become bound to the spot. The substrate is then released and
reacts with the enzyme bound to the captured receptor protein causing a color to develop
at the test spot. If the color of the test spot is weaker than that of the control spot, the
result is indicative of a positive. The main advantages of this type of assay are its ease of
use and rapid testing time, which is approximately ten minutes (Navratilova, 2008) and
these specific, rapid; tests are primarily used by processors and regulator personnel.
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Another common type of screening test is the enzymatic assay. The main type of
enzymatic assay is the Penzyme screening test. The Penzyme test is a qualitative,
enzymatic colorimetric assay for quick determination of β-lactam residues present in
milk. The test principle is based on establishing the level of inactivation of the (DDcarboxypeptidase) enzyme by β-lactam antibiotics. The residues will bind specifically
with the enzyme and inactivate it. The milk sample is added to an ampoule that contains
the enzyme Streptomyces DD-carboxypeptidase. During incubation, any β-lactam
residues present in the sample will create a stable complex with the enzyme. The degree
of inactivation depends on the amount of antibiotics present in the milk sample. After a
reagent pellet is added, incubation takes place. If the sample does not contain β-lactam
residues, the enzyme is hydrolyzed eventually giving rise to two end products, pyruvic
acid and hydrogen peroxide. Hydrogen peroxide is used to oxidize the organic redox
indicator. If the sample is negative, the indicator will change into a pink-orange color. If
a yellow or yellow-orange color is observed, the sample is suspected of containing an
antibiotic residue (Navratilova, 2008). The two main advantages of this assay are the
ease of the use and rapid testing time. Although residue screening tests can detect a wide
range of antibiotics and are simple to use, they are not without their short-comings.
Concerns associated with these qualitative residue screening tests are the variable
rates of sensitivity and specificity across tests and antibiotics. Sensitivity refers to the
likelihood of correct identification of a positive (milk containing a violative concentration
of an antibiotic). Specificity refers to the likelihood of correct identification of a true
negative; milk without violative concentrations of an antibiotic (Van Eenennaam et al.,
1993). Van Eenennaam et al. (1993) evaluated the specificity and sensitivity of the
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Delvotest® and the CITE SNAP test with milk from cows with mild to moderate clinical
mastitis. Sensitivity values were determined from quarter milk samples of the antibiotic
therapy groups after the antibiotic was administered, because these were the only samples
expected to contain detectable levels of antibiotics. Specificity values were determined
from the milk samples of untreated cows because the samples were expected to be free of
antibiotic residues. The Delvotest® was determined to have a high sensitivity (97%) but a
low specificity (38%) (Van Eenennaam et al., 1993). The CITE SNAP also had a high
sensitivity (85%) but a low specificity (30%). A possible explanation for the low
specificity of the Delvotest® and CITE SNAP is that SCC increase in concentration in
milk from infected quarters and have been known to raise the incidences of false positive
readings. The rate of false positive outcomes is much greater when milk from a cow with
clinical mastitis is tested compared to evaluating milk from a normal quarter or quarter
with sub-clinical mastitis (Andrew, 2000).
Andrew (2000) evaluated the specificity rates of four different residue screening
tests including the Delvotest®, the CITE SNAP, and the Penzyme screening test. The
Delvotest® had a high specificity rate of 1.0 when testing milk from Holstein cows and a
rate of 0.98 when testing milk from Jersey cows. The CITE SNAP also had a high
specificity rate of 1.0 when testing milk from Holstein cows and a rate of 0.93 when
testing milk from Jersey cows. The Penzyme test had a low specificity rate of 0.77 when
testing milk from Holstein cows and an even lower rate of 0.53 when testing milk from
Jersey cows. Andrew, (2000) concluded the breed difference was due to the difference in
milk fat (MF) and milk protein (MP) percentage between the two breeds. Jerseys
typically have greater MF and MP percentages in comparison to Holsteins, and
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increasing MF percentage was associated with an increase in the probability of falsepositive outcomes for the CITE SNAP test (Andrew, 2000). Increased MP and increased
SCC were associated with an increase in false-positive outcomes for the Penzyme test.
Due to the fact that the Penzyme test is an enzymatic assay, the proteins from the milk
samples may have interfered with the test results (Andrew, 2000). Based on the results of
this study and previous studies, the CITE SNAP and Delvotest® antibiotic residue
screening tests can be used to evaluate the antibiotic residue levels of milk from Jersey
cows which may have elevated MF and MP production levels (Andrew, 2000).
Organic Agriculture
Organic milk production has become one of the fastest growing sectors of organic
agriculture. In 2007, the Organic Trade Association reported that sales of organic foods
increased by 18% to represent $20 billion in consumer sales. In addition, dairy products
(16%) are only second to fruits and vegetables (40%) as a percentage of overall organic
food purchases (Organic Trade Association, 2007). The United States Department of
Agriculture (USDA) has estimated that organic milk increased from 2% of United States
fluid milk purchases in 2006 to 3% in 2008 (USDA, 2008).
Consumer demand for organic dairy products has led to a dramatic increase in the
proportion of dairy farms switching to organic practices (Ruegg, 2009). Between 2000
and 2005, the number of certified organic dairy cows in the United States increased from
38,000 to more than 86,000 (USDA, 2006). A majority of these cows were housed on
small, conventional dairy facilities that had transitioned to organic production to increase
farm profitability (USDA, 2008). In 2005, Wisconsin housed the highest percentage
(19%) of organic dairy cows in the United States (Ruegg, 2009).
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The increased consumer demand for organic foods is, in part, driven by perceived
concerns about the safety of foods produced on conventional facilities. Consumers are
concerned about potential health risks associated with the use of pesticides and antibiotics
in food production (Ruegg, 2009). Organic dairy products are perceived to be a safer
choice by the public because organic dairy cattle are raised on organic feeds (grown
without the use of pesticides), antibiotics and growth hormones are prohibited, and
husbandry practices are intended to limit stress and promote the health of the dairy herd
(Ruegg, 2009).
The process of organic accreditation is becoming increasingly more regulated.
The USDA National Organic Program (NOP) has defined the standards for organic
production and handling within the United States (USDA, 2008). These standards
address the methods, practices, and substances used in producing and handling crops,
livestock, and processed agricultural products. Under the USDA guidelines, dairy
products must be from animals that have been under continuous organic management for
a minimum of one yr, except during the transition period when entire dairy herds are
being converted to organic practices. For the first nine months (mo) of the yr of
transition, the producer is allowed to feed the herd a minimum of 80% organic feed
(Ruegg, 2009). Once the transition period is completed, the herd must be fed organic
feeds and housed in conditions that provide exercise and freedom of movement to
minimize stress to the animal (USDA, 2008).
One of the most important regulations under the USDA NOP is that most
conventional therapeutic compounds are prohibited for use in dairy cattle on organic
facilities. These compounds include but are not limited to β-lactam antibiotics,
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tetracycline, sulfa drugs, steroids, growth and reproduction hormones, and recombinant
bovine somatotropin (rbST / rBGH / bovine growth hormone). Under current guidelines,
if a prohibited agent is used, the animal will be ineligible for organic milk production
forever (Karreman, 2007).
USDA NOP regulations require producers to provide appropriate medical
treatment to ill cows, but animals that receive treatment from a prohibited source (i.e.
antibiotic, hormone, steroid, etc.) are immediately and permanently disqualified from
organic production. All appropriate treatments and medications must be used to restore
the health of the animal when methods acceptable to organic standards fail to alleviate the
condition (USDA, 2008). Unfortunately, there are no FDA-approved antimicrobial
compounds on the USDA-approved list of allowed organic treatments. In addition, the
FDA guidelines do not allow the use of unapproved substances for IMM therapy,
regardless of whether or not the compound is a natural compound such as a botanical,
homeopathic agent, or food supplement, for the treatment of food-producing animals
even under the supervision of a veterinarian.
Natural Treatments
a. Alternative products for the treatment of mastitis
The treatment of mastitis accounts for the majority of antibiotic usage on
conventional facilities. The most common treatment method for mastitis is IMM infusion
of antibiotics. This method, however, is not available to organic dairy producers (Ruegg,
2009). Organic dairy practices must rely on natural products to treat for mastitis.
In a survey conducted by Pol and Ruegg (2007), Wisconsin farmers reported the
rate of use of natural products for treating mastitis; whey-based products, garlic tincture,
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and aloe were the most commonly used products with a reported usage rate of 45%, 35%
and 30% respectively. The use of aloe is common because it is believed to drain the
infection and soften the udder when it is infused into the quarter. There is no FDA
approval, however, for the IMM use of this and other natural compounds (Ruegg, 2009).
Wisconsin farms surveyed also reported the usage rates of Vitamin C, Aspirin, and
vegetable oils at 25%, 20%, and 20% respectively (Pol and Ruegg, 2007). Topical herbal
ointments containing ginger, peppermint, or lemon extracts are also commonly used and
can be applied to reduce inflammation, although studies have not been done to determine
the efficacy of these products (Karreman, 2007). There have been very few peerreviewed studies that have dealt with the clinical efficacy of natural products for treating
mastitis (Ruegg, 2009).
b. Natural antimicrobials
Several natural lipids have been shown to be effective against microbial growth.
Studies involving fatty acids and their monoglycerides demonstrated that these
compounds could inhibit a variety of pathogenic organisms (Kabara, 1978; Isaacs et al.,
1995; Petschow et al., 1996). Nair et al. (2005) evaluated the antimicrobial activity of
caprylic acid and its monoglyceride, monocaprylin, against mastitis causing pathogens.
Both caprylic acid and monocaprylin were determined to be bactericidal against the
major bovine mastitis pathogens in milk. In this study, Staphylococcus aureus in milk
was reduced from 6.0 log cfu/mL to 1.0 log cfu /mL after six hours (h) of incubation
(Nair et al., 2005).
Plant-derived natural oils have also been studied for their antimicrobial activity.
Trans-cinnamaldehyde, eugenol, carvacrol, and thymol are a group of generally
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recognized as safe (GRAS) natural antimicrobials that are traditionally used to preserve
food and enhance flavor. A study conducted by Ananda Baskaran et al. (2009)
determined the efficacy of these natural antimicrobials against mastitis causing pathogens
(in vitro). The researchers determined the minimum bactericidal concentration (MBC)
and minimum inhibitory concentration (MIC) of each of the natural compounds against
mastitis causing pathogens and determined the efficacy of each of the compounds. All
four compounds were effective against each of the five mastitis pathogens tested but
trans-cinnamaldehyde had the greatest bactericidal activity. Trans-cinnamaldehyde at
the established MBC (0.45%) reduced pathogen populations from 6.0 log cfu/mL to
undetectable levels after 24 h for each of the five pathogens tested (Ananda Baskaran et
al., 2009).
In addition, a commercial herbal remedy, phyto-mast®, is marketed as a potential
treatment for mastitis in cows in organic dairy production. This product is composed of
several organic compounds including Angelica sinensis, Glycyrrhiza uralensis,
Gaultheria procumbens, and Thymus vulgaris (McPhee et al., 2009). There have been
recent studies conducted to evaluate the efficacy of phyto-mast® as a viable treatment for
mastitis. Mullen et al. (2010), compared the efficacy of three different IMM treatments
for mastitis; phyto-mast®, antibiotic treatment, and no treatment, as a DCT. The
researchers found that conventional antibiotic treatment had the highest cure rate and
lowest new infection rate. Cows treated with phyto-mast® however, had fewer new
infections compared to cows receiving no treatment. Even though phyto-mast® was less
effective than antibiotic treatment, the researchers concluded that phyto-mast® has the
potential to be a useful dry cow treatment on organic dairy farms (Mullen et al., 2010). A
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study conducted by Pinedo et al. (2009), evaluated the efficacy of phyto-mast® in treating
clinical mastitis. The researchers reported that cows treated with phyto-mast® had a
faster recovery rate and a higher bacteriological cure rate compared to untreated cows
(Pinedo et al., 2009). There have been no FDA evaluation of this product therefore; the
efficacy of this compound has not been established.
Nisin is a natural compound that is being studied for its efficacy in treating
mastitis. Nisin is an antimicrobial polypeptide that is produced by Lactococcus lactis. It
is a GRAS compound and it has been formulated into products used for teat-dipping;
however, there are few reports on the use of nisin as an IMM mastitis therapy (Sears et
al., 1992). Cao et al. (2007) evaluated the efficacy of nisin compared to gentamicin, an
antibiotic for the treatment of clinical mastitis in lactating dairy cows. The researchers
found that there was no difference between the two antimicrobials in regards to
bacteriological cure rates and clinical cure rates. Nisin however, was significantly more
effective at eliminating Staphylococcus aureus infections compared to gentamicin (Cao et
al., 2007).
In a study done by Zhou et al. (2007), thymol and carvacrol were assessed alone
and in combination against Salmonella typhimurium to determine the antimicrobial
effects of the compounds. The combination of the two antimicrobials was more effective
at reducing the populations of the microorganism compared with milk spiked with thymol
and carvacrol alone (Zhou et al., 2007). Johny et al. (2010) reported similar findings.
The combination of trans-cinnamaldehyde, eugenol, thymol, carvacrol, and
b-resorcylic acid was more effective than the individual compounds at rendering
Salmonella typhimurium susceptible to antibiotics. A study done by Brandt et al. (2010)
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evaluated nisin alone and in combination with acidic calcium sulfate against Listeria
monocytogenes to determine the ability of the compounds to inhibit the growth of the
pathogen. The combination of nisin with acidic calcium sulfate was more effective than
the individual compounds at reducing the growth of Listeria monocytogenes (Brandt et
al., 2010). The results of these studies indicate that these antimicrobials are effective
individually and the antimicrobial effects may be enhanced when the compounds are
administered as a combination (Johny et al., 2010). The results from the above studies
indicate that natural antimicrobials may have the potential to be used alone or in
combination, as an alternative to antibiotics for the treatment of mastitis.
Pasteurization
The vast majority of milk is consumed after pasteurization. Pasteurization is the
process of heat treating raw milk to inactivate or kill potentially harmful pathogens
(Smith, 1981). There have been few studies that have evaluated the effect of heat on the
antimicrobial activity of antibiotics. Zorraquino et al. (2008) tested the effect of varying
heat treatments on milk spiked with different concentrations of β-lactam antibiotics. The
results of the study showed that heating milk at 40 ̊ C for 10 minutes (min) did not cause
heat inactivation for any of the antibiotics whereas milk heated at 83 ̊ C for 10 min
resulted in significant losses in activity for penicillin G, cephalexin, and cefuroxime.
Milk heated at 60 ̊ C for 30 min, however, resulted in a minimal loss in antimicrobial
activity for the antibiotics analyzed (Zorraquino et al., 2008). The heat treatment at 60°C
for 30 min was near the level of the pasteurization. There are very specific requirements
for pasteurization, milk must be heated at 63°C for 30 min, then rapidly cooled in an ice
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bath (Smith, 1981). Natural antimicrobials should also be evaluated in pasteurized milk
to determine if heat causes a loss in their antimicrobial activity.
In summary, with the interest of natural compounds that could potentially be used
as treatments for mastitis, there comes the threat of antimicrobial residues. Milk must be
monitored to prevent contaminated milk from entering the human food supply.
Antibiotic residue screening tests may be able to detect the presence of these natural
antimicrobials in milk. Naturally derived compounds could possibly interfere with the
production of cultured products, such as cheese and yogurt. If antibiotic residue
screening tests are able to detect the presence of antimicrobials then this problem could
be avoided. Screening tests can give producers a means of ensuring the quality of their
products and safety of their milk. This study evaluated the efficacy of antibiotic residue
screening tests for the detection of natural antimicrobials in milk.
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HYPOTHESES
The hypotheses of this study are fourfold:
1) Qualitative antibiotic residue screening tests, particularly microbial inhibition
tests can detect natural antimicrobials in milk.
2) For natural antimicrobials that have established MIC values, it is expected
that these screening tests can detect the natural compounds at their MIC and
concentrations below the MIC (detection limits).
3) Pasteurization does not affect the ability of the residue screening tests to detect
the natural compounds.
4) The combination of natural antimicrobials increases the risk for residues in
milk.

OBJECTIVES
The objectives of this experiment are to determine if the Delvotest® SP-NT and the
IDEXX β –Lactam SNAP test can detect natural antimicrobial compounds in milk,
determine the sensitivity of these antibiotic residue screening tests, and determine the
detection limits for each of these compounds, as well as the effect of pasteurization on the
antimicrobial activity of the compounds and the effect of the combination of compounds
on detection by antibiotic residue screening tests.
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MATERIALS AND METHODS
Animal Selection and Milk Collection
Quarter composite milk was collected from 59 Holstein and 37 Jersey cows from
the University of Connecticut Kellogg Dairy Center during the afternoon milking. Milk
was collected from cows with visually normal milk and mammary gland. Cows had not
been treated with an antibiotic for at least 30 days (d) prior to collection. Milk from
Holstein and Jersey cows was sampled to provide a wide range in MF and MP contents.
The teats were prepared for milking based on the University of Connecticut
Kellogg Dairy Center’s general operating procedures. Briefly, teats were pre-dipped with
an iodine-based product and dried with individual cloth towels. Three streams of
foremilk from each quarter were discarded before sample collection. Fifty mL of quarter
composite milk was collected from each cow.
Milk Fat Content, Milk Protein Content, and Somatic Cell Count Analyses
A subsample of five mL of milk, taken from a composite milk sample, was
analyzed for MF and MP contents by infrared spectroscopy (DAIRY ONE, DHI Milk
Testing Laboratory, Ithaca, NY). Another subsample of five mL of milk, taken from the
50 mL quarter composite milk sample was analyzed for SCC at the University of
Connecticut Veterinary Medical Diagnostic Laboratory. The SCC of each milk sample
was determined using the DeLaval cell counter DCC (DeLaval Inc., Kansas City, MO).
Five additional milk samples with SCC greater than 200 x 103 SCC/mL were analyzed
for each compound to determine if elevated SCC interfered with the accuracy of the
screening tests.
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Caprylic Acid, Plant-Derived Antimicrobials, and Nisin
Caprylic acid, the plant-derived essential oils; trans-cinnamaldehyde, eugenol,
carvacrol, and thymol, (Sigma-Aldrich Chemical Company, St. Louis, MO), phyto-mast®
(Penn Dutch Cow Care, Narvon, PA), and nisin (ImmuCell Corporation, Portland,
Maine) were evaluated for detection in milk using antibiotic residue screening tests. The
compounds, reference numbers and MIC, if known, are presented in Table 1.
Caprylic acid is a medium-chain fatty acid naturally present in milk at low
concentrations (Jensen et al., 1990; Sprong et al., 2001; Jensen, 2002).
Trans-cinnamaldehyde is the primary component of cinnamon oil (Ananda Baskaran et
al., 2009). Eugenol is an active agent in clove oil (Ali et al., 2005), and carvacrol and
thymol are ingredients in oregano oil (Bendahou et al., 2008).
Phyto-mast®, unlike the other antimicrobials, is a commercial product that
contains a mixture of plant-derived essential oils that include Angelica sinensis,
Glycyrrhiza uralensis, Gaultheria procumbens, and Thymus vulgaris. Angelica sinensis
is a flavoring agent for gin, Glycyrrhiza uralensis is a component of licorice, Gaultheria
procumbens is a source of wintergreen flavoring, and Thymus vulgaris is a thyme
flavoring additive (McPhee et al., 2009). Nisin is an antimicrobial polypeptide that is
produced by Lactococcus lactis (Sears et al., 1992).
Determination of the MIC for Phyto-mast®
The method described by Andrews (2001) was used to determine the MIC of the
phyto-mast®. Milk containing phyto-mast® in the range of 0 to 67% (vol/vol) was
inoculated with each of the mastitis pathogens; Staphylococcus aureus, Streptococcus
uberis, and Streptococcus dysagalactiae. Following incubation, the samples were plated
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onto tryptic soy agar plates. The plates were then analyzed to determine the minimum
concentration of phyto-mast® that inhibited the growth of each pathogen (Ananada
Baskaran et al, 2009).
Preparation of spiked milk samples
For each compound, 30 replicates using individual milk samples from 15 Holstein
and 15 Jersey cows, were evaluated for determination of sensitivity by the antibiotic
residue screening tests at the MIC, except for phyto-mast®. Two lower concentrations
were identified for each compound that represented the lowest concentration that would
result in a test sensitivity rate of greater than 0.90 (the detection limit) and the greatest
concentration of the compound where the sensitivity rate was less than 0.03 (below
detection limit). These two concentrations were determined by screening each compound
in small increments over a wide range of concentrations. Within each compound, the
same milk samples were used to determine sensitivity for the three concentrations.
Combination of antimicrobials
Eugenol was combined with either trans-cinnamaldehyde or thymol at their
respective concentrations below the detection limit and evaluated in milk by the residue
screening tests. For each combination, three replicates were tested using individual milk
samples from lactating dairy cows.
Pasteurization of spiked milk samples
Each compound was evaluated in triplicate, at the MIC and detection limit, to
determine if pasteurization had an effect on the antimicrobial activity of the compounds.
The spiked milk samples from individual cows were heated in a water bath at 63° C for
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30 min and then immediately cooled in an ice bath for 60 min as in accordance with the
pasteurized milk ordinance (PMO) standards for batch pasteurization (FDA, 2009).
Determination of sensitivities and detection limit of compounds
The spiked milk samples were analyzed for the presence of inhibitors by two
commercially available, antibiotic residue screening tests, the Delvotest® SP –NT
(Nelson-Jameson Inc., Marshfield, WI) and the SNAP β-lactam test (IDEXX
Laboratories Inc., Westbrook, ME). The Delvotest® SP –NT is a microbial growth
inhibition test that detects β-lactam and sulfur antibiotics and the SNAP β-lactam test is
an antibiotic-antigen capture test.
For each day of analysis, standard positive (Nelson-Jameson Inc., Marshfield, WI,
Delvotest® Penicillin G Standard Control, 5 ppb) and negative control samples (NelsonJameson Inc., Marshfield, WI, Delvotest® Negative Control, 5 ppb) were analyzed along
with the milk samples for both residue screening tests to verify the accuracy of the tests.
Statistical Analyses
A sensitivity rate (the rate of truly positive samples that were found to be positive
by the Delvotest® SP-NT) and a 95% confidence interval were calculated for each
compound at each concentration (Van Eenennaam et al., 1993). A sensitivity rate of 1.0
indicated that all samples that contained a compound were found to be positive by the
Delvotest® SP-NT. SCC were converted to somatic cell scores and the effect of SCC,
MF, and MP on the sensitivity rates of the Delvotest® SP-NT was evaluated using PROC
LOGISTIC (SAS Inst, Inc., Cary, NC).
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RESULTS AND DISCUSSION
Over a 14 mo period, 185 quarter composite milk samples were collected from 59
Holstein and 37 Jersey cows. Throughout the course of the study, several cows were
sampled more than once at different stages of lactation. Mean MF and mean MP
concentrations were typical of breed averages (Wiggans, 2006) and were greater for milk
from Jersey cows than milk from Holstein cows, as expected (Table 2). The SCC ranged
from 3 x 103 cells/mL to 841 x 103 cells/mL across both breeds. There were five
additional milk samples collected from three Jersey and two Holstein cows, with a
geometric SCC mean of 552 x 103 cells/mL and a range from 200 x 103 cells/mL to 5965
x 103 cells/mL. MP and MF contents, and SCC did not affect the outcome of the
Delvotest® SP-NT and all results are summarized across breeds.
Phyto-mast® did not inhibit the growth of the mastitis pathogens and; therefore,
the MIC could not be determined. In a study by Pinedo et al. (2009), phyto-mast® was
compared to no treatment for treating cows with clinical mastitis. The study found that
there were no differences in cure rates between the two treatments but, there was a
tendency for a faster recovery rate for cows treated with phyto-mast® compared to no
treatment A study conducted by Mullen et al. (2010) reported similar results in relation
to cure rates between phyto-mast® and no treatment. Phyto-mast® had the same cure
rates as no treatment for bacteria present in the quarters of dry cows; however, in
contrast, phyto-mast® tended to be more effective at preventing new infections than no
treatment (Mullen et al., 2010). Previous research and the present study both indicate
that the product may not be effective against mastitis pathogens and has not been
evaluated by the FDA.
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The IDEXX SNAP β-lactam test did not detect any of the antimicrobials
investigated in this study. The SNAP test is specific to the basic common structure of
β-lactam antibiotics. The compounds tested do not have a similar ring structure and;
therefore, it was not expected that the SNAP test would detect the compounds evaluated
in this study.
All positive and negative control milk samples were identified correctly by the
Delvotest® SP-NT. The Delvotest® SP-NT detected caprylic acid and the plant-derived
antimicrobials at their MIC values with sensitivities of 1.0 (Table 3). The established
detection limits (DL), were lower than the MIC for these compounds, with the exception
of trans-cinnamaldehyde. The MIC and DL were the same concentration for
trans-cinnamaldehyde. The sensitivity rates of the Delvotest® SP-NT for the DL ranged
from 0.93 to 1.0 for the compounds evaluated. The concentration, at which the
antimicrobials could no longer be detected by the Delvotest® SP-NT, below the detection
limit (BDL), differed for each compound, and were below the MIC and DL for all of the
compounds (Table 3). These results demonstrate that the bacteria, Bacillus
stearothermophilus, of the Delvotest® SP-NT, was more sensitive to caprylic acid and the
plant-derived natural antimicrobials than the sensitivities of the mastitis pathogens.
The sensitivity of the Delvotest® SP-NT for nisin was 1.0 at the MIC and the DL
(Table 4). The DL of nisin, by the Delvotest® SP-NT, was 400 fold less than that of that
of the MIC. The MIC of nisin is markedly lower than for the other compounds evaluated
in this study (Table 1), but similar to the MIC for several conventional antibiotics; such
as ampicillin and amoxicillin (Tenhagen et al., 2006). The residue screening tests are
designed to detect antibiotics below their MIC and tolerance and/or safe levels to protect
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human food safety (FDAa, 2010); therefore, it is expected that all compounds would be
detected by the screening test below their respective MIC values.
Although the MIC for several mastitis pathogens could not be established for
phyto-mast® in this study, the Delvotest® SP-NT detected phyto-mast® at a concentration
of 12.5% in milk (Table 4). The BDL for phyto-mast® was established to be 6.25% in
milk. These concentrations for the DL and BDL are much greater for phyto-mast®
compared to the other compounds evaluated in this study and conventional antibiotics
(Thornsberry et al., 1996). Phyto-mast® is a suspension of a mixture of compounds and
the specific concentrations of each compound in the mixture have not been published.
These results indicate that the test organism in the microbial inhibition test was more
sensitive to the compounds in phyto-mast® than for Staphylococcus aureus, Streptococcus
uberis, and Streptococcus dysagalactiae when phyto-mast® was at a concentration of up
to 67% in milk. Although, the phyto-mast® mixture did not inhibit mastitis pathogen
growth, it can be detected by the Delvotest® SP-NT when present at high concentrations
in milk.
There was variability among the compounds in their sensitivities to the screening
test organism. Nisin was the most sensitive compound with a DL 99.8% less than its
MIC (Table 5). Trans-cinnamaldehyde was the most sensitive of the plant-derived
essential oils. The MIC of trans-cinnamaldehyde was less than the DLs of the other
compounds evaluated, with the exception of nisin. The sensitivities of the screening test
organism for caprylic acid, eugenol, and carvacrol were similar with DLs of 60%, 66.9%,
and 70% less than their MIC, respectively. The DL for thymol demonstrated that the
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screening test had a lower degree of sensitivity compared to that of the other compounds
tested in this study.
The efficacy of the Delvotest® SP-NT to detect the plant-derived essential oils
may be due to the high degree of hydrophobicity which enable them to target the lipidcontaining cell membrane of the test bacteria, Bacillus stearothermophilus, a Grampositive bacterium, in the screening test (Knobloch et al., 1986, Sikkema et al., 1994).
These compounds may have disrupted the membrane of the Bacillus stearothermophilus,
present in the agar, inhibiting its growth (Cox et al., 2000; Carson et al., 2002; Ultee et
al., 2002). The antimicrobial action of caprylic acid, the medium-chain fatty acid, may
be via its ability to diffuse across the cell membranes of bacteria and subsequent
inhibition of growth of the bacteria (Nair et al., 2005). Several studies indicate that
Gram-negative bacteria are less sensitive to the antimicrobial effects of fatty acids than
Gram-positive bacteria (Kabara, 1978; Monk et al., 1996).
Nisin has been shown to have high antibacterial activity and because of this it is
commonly used as a food preservative; especially for canned foods and dairy products
(Cao et al, 2007). Gram-positive bacteria are especially sensitive to the bactericidal
activity of nisin (Deegan et al, 2005). This may be a possible explanation for why the
screening test was highly sensitive to nisin.
The pasteurization of milk did not have an effect on the outcome of the
Delvotest® SP-NT, indicating that the antimicrobial activity of the compounds were not
affected by heat treatment. This result is similar to the result reported by the Zorraquino
et al. (2008) in that milk spiked with β-lactam antibiotics, heated at 60°C for 30 min,
caused minimal to no loss in the antimicrobial activity of the antibiotics. Also, the
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Delvotest® SP-NT detected the combination of eugenol and trans-cinnamaldehyde and
eugenol and thymol at their respective concentrations below their DL, thus demonstrating
the additive antimicrobial activity of eugenol combined with either trans-cinnamaldehyde
or thymol. When these antimicrobials were analyzed alone below their respective DL,
the Delvotest® SP-NT did not detect them. This result is in agreement with the data
reported from the studies of Zhou et al. (2007) and Johny et al. (2010). They determined
that combinations of natural antimicrobial compounds were more effective at reducing
populations of Salmonella typhimurium than treating with one compound alone.
Holstein and Jersey cows were selected for this study because Jersey cows
typically have greater concentrations of MF and MP, which could affect the outcome of
the Delvotest ® SP-NT. In a study done by Andrew (2000), the specificity rates (rate of
truly negative samples that were found negative) were lower when milk collected from
Jersey cows was evaluated in comparison to milk evaluated from Holstein cows. Greater
concentrations of MF and MP may interfere with the performance of the screening tests
either by inhibiting the growth of the test organism for microbial inhibition tests or
affecting the chemical reactions in the specific residue screening tests. Sischo and Burns
(1993) reported that an increased SCC was associated with an increase in the rate of false
positive outcomes for the Delvotest-P® (Sischo and Burns, 1993). This association was
also found in a study by Van Eenennaam et al. (1993). The researchers evaluated the
efficacy of four residue screening tests, including the IDEXX CITE® Probe (β-lactam)
and the Delovtest-P®, for cows recovering from mastitis. Milk containing SCC of greater
than 106 cells/mL was associated with a greater number of false-positive outcomes for
both the CITE® SNAP and the Delovtest-P® screening tests (Van Eenennaam, 1993). In
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the current study, elevated SCC did not interfere with the ability of the Delvotest® SP-NT
to detect the natural antimicrobials; and therefore, the screening tests may be useful in
identifying these compounds in milk across a wide range in MF, MP, and SCC.
CONCLUSION
The results of this study support the hypothesis that microbial inhibition tests can
detect the natural antimicrobials at their MIC, for all the compounds evaluated, and
concentrations below the MIC, for all the compounds with the exception of
trans-cinnamaldehyde. The treatment of mastitis constitutes the majority of antibiotic
usage on conventional dairy farms. The treatment of IMM infusion of antibiotics is
prohibited on organic facilities; therefore, “natural antimicrobials” such as the
compounds in this study may have the potential to be efficacious, meet organic standards,
and be evaluated for approval by the FDA. This study has clearly demonstrated that the
microbial inhibition antibiotic residue screening test, the Delvotest® SP-NT, can detect
these natural antimicrobials and indicate that these compounds may, like nisin affect
microbial activity of cultured milk products. Microbial inhibition tests, like the
Delvotest® SP-NT, can provide producers the means of ensuring the quality of their
products. These findings may be useful to producers, regulatory agencies, and processing
plants for assurance of safety and quality of milk produced by organic dairy facilities.
Further in vivo research is needed to determine the effect of these natural antimicrobials
on milk quality and cultured dairy products.
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Table 1. List of antimicrobials, their commercial reference numbers, and their minimum
inhibitory concentration (MIC).
Antimicrobial

Reference no.

MIC (mM)

Caprylic Acid

1537531,2

Trans-cinnamaldehyde

2399681,3

Eugenol

E517911,3

36.5

Carvacrol

2821971,3

33.3

Thymol

T05011,3

39.9

50.0
7.57

Nisin4

___

2.005,6

Phyto-mast® 7

___

___

1

Sigma-Aldrich Chemical Company, St. Louis, MO
MIC determined by Nair et al., 2005
3
MIC determined by Ananda Baskaran et al., 2009
4
ImmuCell Corporation, Portland, Maine
5
MIC determined by Piper et al., 2009
6
MIC expressed in nM
7
Penn Dutch Cow Care, Narvon, PA

2
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Table 2. Somatic cell count (SCC), milk fat and milk protein contents for Holstein and
Jersey cows that were sampled for the detection of caprylic acid, trans-cinnamaldehyde,
eugenol, carvacrol, thymol, and phyto-mast® in milk by the Delvotest® SP-NT.
Variable
Holstein (n=59)
SCC (x 103/mL)
Milk fat (%)
Milk protein (%)
Jersey (n=37)
SCC (x 103/mL)
Milk fat (%)
Milk protein (%)

Mean

Minimum

Maximum

53
3.20
2.80

4
2.10
2.40

400
4.70
3.40

107
4.30
3.40

3
3.00
2.60

841
5.40
4.10
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Table 3. Sensitivity rates for the Delvotest® SP-NT using milk spiked with caprylic acid,
trans-cinnamaldehyde (TC), carvacrol, eugenol, and thymol at three different
concentrations including the minimum inhibitory concentration (MIC), the detection limit
(DL), and greatest concentration below the detection limit (BDL).

Antimicrobial

Inhibitory
activity
measures

Concentration
(mM)

Number
positive

50.0
20.0
10.0

28
28
1

Sensitivity
rate

Lower
CI1

Upper
CI2

0.93
0.93
0.03

0.76
0.76
0.001

0.99
0.99
0.19

Caprylic Acid

MIC
DL
BDL

TC

MIC
BDL

7.57
2.27

30
0

1.0
0

0.86
0

1.0
0

Carvacrol

MIC
DL
BDL

33.3
9.98
3.33

30
29
1

1.0
0.96
0.03

0.86
0.81
0.001

1.0
0.99
0.19

Eugenol

MIC
DL
BDL

36.5
12.2
3.05

30
30
1

1.0
1.0
0.03

0.86
0.86
0.001

1.0
1.0
0.19

39.9
16.6
6.65

30
30
0

1.0
1.0
0

0.86
0.86
0

1.0
1.0
0

Thymol

MIC
DL
BDL
1
Lower 95% confidence interval
2
Upper 95% confidence interval
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Table 4. Sensitivity rates for the Delvotest® SP-NT using milk from Jersey (n=15) and
Holstein cows (n=15) spiked with nisin and phyto-mast® at the minimum inhibitory
concentration (MIC), the detection limit (DL), and below the detection limit (BDL).

Antimicrobial
Nisin

Inhibitory
activity
measures
MIC
DL
BDL

Concentration
(nM)

Number
positive

Sensitivity
rate

Lower
CI1

Upper
CI2

2.00
0.005
0.0025

30
30
0

1.0
1.0
0

0.86
0.86
0

1.0
1.0
0

30
1

1.0
0.03

0.86
0.001

1.0
0.19

Phyto-mast®

DL
1253
BDL
62.53
1
Lower 95% confidence interval
2
Upper 95% confidence interval
3
Expressed in µL/mL of milk
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Table 5. Minimum inhibitory concentration (MIC), detection limit (DL) and percent DL
relative to MIC (% DL:MIC) for the Delvotest® SP-NT using milk spiked with caprylic
acid, trans-cinnamaldehyde, eugenol, carvacrol, thymol, and nisin (expressed in mM).
Antimicrobial

MIC

DL

Caprylic Acid

50.0

20.0

Trans-cinnamaldehyde

7.57

Eugenol

36.5

Carvacrol

33.3

Thymol

39.9

Nisin
1
2

7.57
12.2
9.98
16.6

2.002

0.0052

% DL:MIC 1
60.0
0
66.9
70.0
58.4
99.8

DL relative to MIC for each compound. Calculated as (MIC –DL) / (MIC) x 100
Expressed in nM
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